Regarding B cells, Zhang et al. [45] demonstrated that not only BRL-50481 and IR-202, inhibitors of PDE7, but also IR-284, a dual PDE4/PDE7 inhibitor, increased apoptosis in chronic lymphocytic leukemia (CLL) cells. This evidence concerns the gene PDE4A and B-cell chronic lymphocytic leukemia.